{"url_path":"/sec/aee/8-k/2026-03-04/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 ****Financial Statements and Exhibits.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-03-04","source_url":"https://www.sec.gov/Archives/edgar/data/1002910/0001104659-26-023352-index.html","accession_number":"0001104659-26-023352","cik":"0001002910","ticker":"AEE","issuer_name":"AMEREN CORP","edgar_url":"https://www.sec.gov/Archives/edgar/data/1002910/0001104659-26-023352-index.html","primary_entity_key":"0001002910","primary_entity_name":"AMEREN CORP"},"word_count":216,"has_tables":true,"body_markdown":"**ITEM 9.01****Financial Statements and Exhibits.**\n\n \n\n(d)Exhibits\n\n \n\nExhibit Number\nTitle\n\n \n\n[1](tm267933d1_ex1.htm)[Underwriting Agreement, dated February 26, 2026, between Ameren and BNY Mellon Capital Markets,\nLLC, J.P. Morgan Securities LLC, RBC Capital Markets, LLC, U.S. Bancorp Investments, Inc. and Wells Fargo Securities, LLC, as the\nseveral underwriters named therein.](tm267933d1_ex1.htm)\n\n \n\n[4.1*](https://www.sec.gov/Archives/edgar/data/1002910/000091205702003420/a2068781zex-4_5.txt)[Indenture, dated as of December 1, 2001, by and between Ameren and The Bank of New York Mellon Trust\nCompany, N.A., as successor trustee, (“Ameren Indenture”) (Exhibit 4.5, File No. 333-81774).](https://www.sec.gov/Archives/edgar/data/1002910/000091205702003420/a2068781zex-4_5.txt)\n\n \n\n[4.2*](https://www.sec.gov/Archives/edgar/data/18651/000100291008000126/exhibit4_1.htm)[First Supplemental Indenture, dated as of May 19, 2008, to the Ameren Indenture (June 30, 2008 Form\n10-Q, Exhibit 4.1, File No. 1-14756).](https://www.sec.gov/Archives/edgar/data/18651/000100291008000126/exhibit4_1.htm)\n\n \n\n[4.3](tm267933d1_ex4-3.htm)[Company Order, dated March 4, 2026, establishing the Notes.](tm267933d1_ex4-3.htm)\n\n \n\n[4.4](tm267933d1_ex4-4.htm)[Global Note.](tm267933d1_ex4-4.htm)\n\n \n\n[5.1](tm267933d1_ex5-1.htm)[Opinion of Stephen C. Lee, Esq., Vice President and Deputy General Counsel of Ameren, regarding\nthe legality of the Notes (including consent).](tm267933d1_ex5-1.htm)\n\n \n\n[5.2](tm267933d1_ex5-2.htm)[Opinion of Morgan, Lewis & Bockius LLP regarding the legality of the Notes (including consent).](tm267933d1_ex5-2.htm)\n\n \n\n104Cover Page Interactive Data File (formatted as Inline XBRL).\n\n \n\n \n\n*Incorporated by reference as indicated.\n\n \n\n- 2 -\n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant to the requirements of the Securities\nExchange Act of 1934, Ameren has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n AMEREN CORPORATION\n\n(Registrant)\n\n   \n\nBy:/s/\nLeonard P. Singh\n\nName:Leonard P. Singh\n\nTitle:Executive Vice President and Chief\nFinancial Officer\n\n \n\nDate:\nMarch 4, 2026"}